NFE2L2 and breast carcinoma: Previous studies have reported that NFE2L2 is highly expressed in GC and has anti-inflammatory and antioxidant effects [22–24], while DLST has been studied in neuroblastoma, breast cancer, and other tumor diseases [25, 26], and GC-related studies are rare.